Health Care

4266 posts
Image of a woman holding a bottle of hemp oil

Little Green Pharma jumps into distribution with acquisition

Little Green Pharma is aiming to make the strategic acquisition of HH (Australia) Pty Ltd to…
Image of cancer cells

Radiopharm approved to start Lu-RAD202 safety trials, door open for in-human studies

Radiopharm Theranostics has received ethics approval for its trial into Lu-RAD202, a novel treatment for these…
Close up of a nasal spray

LTR Pharma pairs with Men’s Health Downunder for supply of erectile dysfunction spray

LTR Pharma Ltd has signed an agreement with Men's Health Downunder to facilitate supply of its…
Immune system concept ai gen

Immutep dips as safety test for flagship drug IMP761 shows no adverse effects

Immutep has reported a small-scale conceptual safety test among 5 patients using flagship drug IMP761 has…
Excessive sweat

First Sofdra prescriptions for excessive sweating condition pushes Botanix towards full commercial launch

Botanix has reported the first prescriptions of its drug Sofdra (sofpironium) to treat hyperhidrosis, a condition…
AI image of a pile of coins and a chart

PainChek rolls out $5.1M capital raising to grow app footprint across multiple markets

PainChek Ltd has raised $5.1M in an Entitlement Offer to facilitate expansion of its Adult App…
3D image of the lungs

4DMedical takes ‘next step’ for turbocharge lung care tech by inking UChicago Medicine deal

4DMedical (ASX:4DX) has inked a deal with the University of Chicago Medicine in the United States.
3D model of a brain concept

Invex reports success in using exenatide to delay Alzheimers in ‘microtissue’ simulation

Invex has reported success simulating the use of Exenatide to improve cell survival in a 3D…
Cancer concept

INOVIQ: Conceptual success killing breast cancer cells with exosomes

INOVIQ Ltd (ASX:IIQ) has reported early-stage in-vitro success using exosomes from natural killer cells to attack…
Nitroglycerin chemical structure

Acrux scores fourth FDA approval, Nitroglycerin Ointment moving into commercialisation

Acrux Ltd has achieved the fourth approval from the US FDA, with its Nitroglycerin Ointment 0.4%,…